Phase II Study of Glucocerebrosidase in Patients With Gaucher Disease

NCT00004293 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

24

Enrollment

NIH

Sponsor class

Conditions

Gaucher's Disease

Interventions

DRUG: glucocerebrosidase

Sponsor

National Center for Research Resources (NCRR)

Collaborators

[object Object]